Table 1. Patient and tumour characteristics.
| Variables | Number of patients (%) |
| Sex | |
| Male | 47 (88.7) |
| Female | 6 (11.3) |
| ECOG performance status | |
| 0–1 | 46 (86.8) |
| 2 | 7 (13.2) |
| Child–Pugh class | |
| A | 43 (81.1) |
| B–C | 10 (18.9) |
| AFP | |
| <400 | 38 (71.7) |
| ≥400 | 15 (28.3) |
| Tumour size | |
| <10 cm | 41 (77.4) |
| ≥10 cm | 12 (22.6) |
| LN metastasis | |
| Positive | 8 (15.1) |
| Negative | 45 (84.9) |
| Distant metastasis | |
| Positive | 7 (13.2) |
| Negative | 46 (86.8) |
| Ascites | |
| Positive | 12 (22.6) |
| Negative | 41 (77.4) |
| Pulmonary disease | |
| Positive | 8 (15.1) |
| Negative | 45 (84.9) |
AFP, alpha-fetoprotein; ECOG, Eastern Cooperative Oncology Group; LN, lymph node.